日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Unlocking the gut-liver axis: microbial contributions to the pathogenesis of metabolic-associated fatty liver disease

揭开肠-肝轴的奥秘:微生物在代谢相关脂肪肝疾病发病机制中的作用

Buchynskyi, Mykhailo; Kamyshna, Iryna; Halabitska, Iryna; Petakh, Pavlo; Kunduzova, Oksana; Oksenych, Valentyn; Kamyshnyi, Oleksandr

War, diet, and PTSD in Ukrainian youth

战争、饮食和创伤后应激障碍对乌克兰青年的影响

Halabitska, Iryna; Petakh, Pavlo; Buchynskyi, Mykhailo; Kamyshna, Iryna; Lushchak, Oleh; Kamyshnyi, Oleksandr

Genetic Predictors of Paxlovid Treatment Response: The Role of IFNAR2, OAS1, OAS3, and ACE2 in COVID-19 Clinical Course.

帕克洛维治疗反应的遗传预测因子:IFNAR2、OAS1、OAS3 和 ACE2 在 COVID-19 临床病程中的作用

Buchynskyi Mykhailo, Kamyshna Iryna, Halabitska Iryna, Petakh Pavlo, Oksenych Valentyn, Kamyshnyi Oleksandr

Exploring Paxlovid Efficacy in COVID-19 Patients with MAFLD: Insights from a Single-Center Prospective Cohort Study

探索帕洛维德治疗合并代谢相关脂肪肝的COVID-19患者的疗效:一项单中心前瞻性队列研究的启示

Buchynskyi, Mykhailo; Oksenych, Valentyn; Kamyshna, Iryna; Kamyshnyi, Oleksandr

Genomic insight into COVID-19 severity in MAFLD patients: a single-center prospective cohort study

基因组学视角揭示MAFLD患者COVID-19病情严重程度:一项单中心前瞻性队列研究

Buchynskyi, Mykhailo; Oksenych, Valentyn; Kamyshna, Iryna; Budarna, Olena; Halabitska, Iryna; Petakh, Pavlo; Kamyshnyi, Oleksandr

Efficacy of interferon alpha for the treatment of hospitalized patients with COVID-19: A meta-analysis

干扰素α治疗COVID-19住院患者的疗效:一项荟萃分析

Buchynskyi, Mykhailo; Kamyshna, Iryna; Lyubomirskaya, Katerina; Moshynets, Olena; Kobyliak, Nazarii; Oksenych, Valentyn; Kamyshnyi, Aleksandr

Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive Analysis

COVID-19 合并代谢性脂肪性肝病病程的遗传预测因子:一项综合分析

Buchynskyi, Mykhailo; Oksenych, Valentyn; Kamyshna, Iryna; Vari, Sandor G; Kamyshnyi, Aleksandr